ICD-10-CM Billable Code

D3A.098

Benign carcinoid tumors of other sites

Clinical Classification Guidelines

Medical Intelligence & Overview

Benign carcinoid tumors are slow-growing neoplasms that originate from neuroendocrine cells found throughout the body. When these tumors occur in sites outside the common regions like the gastrointestinal tract or lungs, they are classified under ICD-10 code D3A.098 as benign carcinoid tumors of other sites. These tumors generally do not spread aggressively and typically have a good prognosis with proper management. Although considered benign, due to their potential to produce hormones or cause local complications, accurate diagnosis and treatment are essential for optimal health outcomes.

Causes & Symptoms

Clinical Causes: Genetic factors that may predispose individuals to develop neuroendocrine tumors Unknown environmental influences that could contribute to tumor formation Developmental anomalies of neuroendocrine cells in various tissues Potential association with certain hereditary syndromes, although rare

Key Symptoms: Depending on the tumor's location, symptoms may be minimal or absent in early stages Local swelling or a palpable mass Hormonal symptoms if the tumor produces bioactive substances, such as flushing, wheezing, or diarrhea Pain or discomfort at the tumor site Unexplained weight loss or fatigue in some cases

Diagnostic & Treatment

Diagnosis Path: Imaging techniques such as CT scans, MRI, or somatostatin receptor scintigraphy to locate tumor sites Biopsy of the suspected tumor tissue for histopathological examination Blood and urine tests to detect hormones or other bioactive substances released by the tumor Endoscopic procedures when applicable to visualize accessible sites

Treatment Protocols: Surgical excision of the tumor to achieve complete removal and prevent recurrence Monitoring through regular follow-up and imaging for asymptomatic or small tumors Medical management, such as somatostatin analogs, if hormone production causes symptoms Supportive care to address any compressive effects or complications arising from the tumor

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D3A.098 a billable ICD-10 code?
Yes, D3A.098 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D3A.098?
Clinical documentation must specify the nature of Benign carcinoid tumors of other sites and any associated comorbidities for accurate reporting.

Cite this Clinical Reference